HAI is a term used to describe all infections that do not stem from the patient?s original diagnosis on admission.
HAIs are caused by bacteria, viruses or parasites that originate from the hospital environment, contaminated equipment, staff, or other patients. The most common types are urinary tract infections, chest infections, and surgical wound infections.
This report aims to provide a comprehensive presentation of the global market for Hospital-Acquired Infection Control, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Hospital-Acquired Infection Control. This report contains market size and forecasts of Hospital-Acquired Infection Control in global, including the following market information:
Global Hospital-Acquired Infection Control Market Revenue, 2018-2023, 2024-2030, ($ millions)
Global top five companies in 2022 (%)
The global Hospital-Acquired Infection Control market was valued at US$ 5867.2 million in 2022 and is projected to reach US$ 7101.9 million by 2029, at a CAGR of 2.8% during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is to reach $ Million.
Catheter-associated Urinary Tract Infections (CAUTIs) Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Hospital-Acquired Infection Control include GSK, Merck, Pfizer, 3M, Abbott, BD, Cepheid and Getinge Group, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
We surveyed the Hospital-Acquired Infection Control companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Hospital-Acquired Infection Control Market, by Type, 2018-2023, 2024-2030 ($ millions)
Global Hospital-Acquired Infection Control Market Segment Percentages, by Type, 2022 (%)
Catheter-associated Urinary Tract Infections (CAUTIs)
Surgical Site Infections (SSIs)
Central Line-associated Bloodstream Infections (CLABSIs)
Respiratory Infections
Global Hospital-Acquired Infection Control Market, by Application, 2018-2023, 2024-2030 ($ millions)
Global Hospital-Acquired Infection Control Market Segment Percentages, by Application, 2022 (%)
Hospitals and ICUs
Outpatient Care Centers
Long-term Care Facilities (LTCFs)
Global Hospital-Acquired Infection Control Market, By Region and Country, 2018-2023, 2024-2030 ($ Millions)
Global Hospital-Acquired Infection Control Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Hospital-Acquired Infection Control revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Hospital-Acquired Infection Control revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
GSK
Merck
Pfizer
3M
Abbott
BD
Cepheid
Getinge Group
Outline of Major Chapters:
Chapter 1: Introduces the definition of Hospital-Acquired Infection Control, market overview.
Chapter 2: Global Hospital-Acquired Infection Control market size in revenue.
Chapter 3: Detailed analysis of Hospital-Acquired Infection Control company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Hospital-Acquired Infection Control in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Hospital-Acquired Infection Control Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Hospital-Acquired Infection Control Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Hospital-Acquired Infection Control Overall Market Size
2.1 Global Hospital-Acquired Infection Control Market Size: 2022 VS 2030
2.2 Global Hospital-Acquired Infection Control Market Size, Prospects & Forecasts: 2018-2030
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Hospital-Acquired Infection Control Players in Global Market
3.2 Top Global Hospital-Acquired Infection Control Companies Ranked by Revenue
3.3 Global Hospital-Acquired Infection Control Revenue by Companies
3.4 Top 3 and Top 5 Hospital-Acquired Infection Control Companies in Global Market, by Revenue in 2022
3.5 Global Companies Hospital-Acquired Infection Control Product Type
3.6 Tier 1, Tier 2 and Tier 3 Hospital-Acquired Infection Control Players in Global Market
3.6.1 List of Global Tier 1 Hospital-Acquired Infection Control Companies
3.6.2 List of Global Tier 2 and Tier 3 Hospital-Acquired Infection Control Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Hospital-Acquired Infection Control Market Size Markets, 2022 & 2030
4.1.2 Catheter-associated Urinary Tract Infections (CAUTIs)
4.1.3 Surgical Site Infections (SSIs)
4.1.4 Central Line-associated Bloodstream Infections (CLABSIs)
4.1.5 Respiratory Infections
4.2 By Type - Global Hospital-Acquired Infection Control Revenue & Forecasts
4.2.1 By Type - Global Hospital-Acquired Infection Control Revenue, 2018-2023
4.2.2 By Type - Global Hospital-Acquired Infection Control Revenue, 2024-2030
4.2.3 By Type - Global Hospital-Acquired Infection Control Revenue Market Share, 2018-2030
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Hospital-Acquired Infection Control Market Size, 2022 & 2030
5.1.2 Hospitals and ICUs
5.1.3 Outpatient Care Centers
5.1.4 Long-term Care Facilities (LTCFs)
5.2 By Application - Global Hospital-Acquired Infection Control Revenue & Forecasts
5.2.1 By Application - Global Hospital-Acquired Infection Control Revenue, 2018-2023
5.2.2 By Application - Global Hospital-Acquired Infection Control Revenue, 2024-2030
5.2.3 By Application - Global Hospital-Acquired Infection Control Revenue Market Share, 2018-2030
6 Sights by Region
6.1 By Region - Global Hospital-Acquired Infection Control Market Size, 2022 & 2030
6.2 By Region - Global Hospital-Acquired Infection Control Revenue & Forecasts
6.2.1 By Region - Global Hospital-Acquired Infection Control Revenue, 2018-2023
6.2.2 By Region - Global Hospital-Acquired Infection Control Revenue, 2024-2030
6.2.3 By Region - Global Hospital-Acquired Infection Control Revenue Market Share, 2018-2030
6.3 North America
6.3.1 By Country - North America Hospital-Acquired Infection Control Revenue, 2018-2030
6.3.2 US Hospital-Acquired Infection Control Market Size, 2018-2030
6.3.3 Canada Hospital-Acquired Infection Control Market Size, 2018-2030
6.3.4 Mexico Hospital-Acquired Infection Control Market Size, 2018-2030
6.4 Europe
6.4.1 By Country - Europe Hospital-Acquired Infection Control Revenue, 2018-2030
6.4.2 Germany Hospital-Acquired Infection Control Market Size, 2018-2030
6.4.3 France Hospital-Acquired Infection Control Market Size, 2018-2030
6.4.4 U.K. Hospital-Acquired Infection Control Market Size, 2018-2030
6.4.5 Italy Hospital-Acquired Infection Control Market Size, 2018-2030
6.4.6 Russia Hospital-Acquired Infection Control Market Size, 2018-2030
6.4.7 Nordic Countries Hospital-Acquired Infection Control Market Size, 2018-2030
6.4.8 Benelux Hospital-Acquired Infection Control Market Size, 2018-2030
6.5 Asia
6.5.1 By Region - Asia Hospital-Acquired Infection Control Revenue, 2018-2030
6.5.2 China Hospital-Acquired Infection Control Market Size, 2018-2030
6.5.3 Japan Hospital-Acquired Infection Control Market Size, 2018-2030
6.5.4 South Korea Hospital-Acquired Infection Control Market Size, 2018-2030
6.5.5 Southeast Asia Hospital-Acquired Infection Control Market Size, 2018-2030
6.5.6 India Hospital-Acquired Infection Control Market Size, 2018-2030
6.6 South America
6.6.1 By Country - South America Hospital-Acquired Infection Control Revenue, 2018-2030
6.6.2 Brazil Hospital-Acquired Infection Control Market Size, 2018-2030
6.6.3 Argentina Hospital-Acquired Infection Control Market Size, 2018-2030
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Hospital-Acquired Infection Control Revenue, 2018-2030
6.7.2 Turkey Hospital-Acquired Infection Control Market Size, 2018-2030
6.7.3 Israel Hospital-Acquired Infection Control Market Size, 2018-2030
6.7.4 Saudi Arabia Hospital-Acquired Infection Control Market Size, 2018-2030
6.7.5 UAE Hospital-Acquired Infection Control Market Size, 2018-2030
7 Hospital-Acquired Infection Control Companies Profiles
7.1 GSK
7.1.1 GSK Company Summary
7.1.2 GSK Business Overview
7.1.3 GSK Hospital-Acquired Infection Control Major Product Offerings
7.1.4 GSK Hospital-Acquired Infection Control Revenue in Global Market (2018-2023)
7.1.5 GSK Key News & Latest Developments
7.2 Merck
7.2.1 Merck Company Summary
7.2.2 Merck Business Overview
7.2.3 Merck Hospital-Acquired Infection Control Major Product Offerings
7.2.4 Merck Hospital-Acquired Infection Control Revenue in Global Market (2018-2023)
7.2.5 Merck Key News & Latest Developments
7.3 Pfizer
7.3.1 Pfizer Company Summary
7.3.2 Pfizer Business Overview
7.3.3 Pfizer Hospital-Acquired Infection Control Major Product Offerings
7.3.4 Pfizer Hospital-Acquired Infection Control Revenue in Global Market (2018-2023)
7.3.5 Pfizer Key News & Latest Developments
7.4 3M
7.4.1 3M Company Summary
7.4.2 3M Business Overview
7.4.3 3M Hospital-Acquired Infection Control Major Product Offerings
7.4.4 3M Hospital-Acquired Infection Control Revenue in Global Market (2018-2023)
7.4.5 3M Key News & Latest Developments
7.5 Abbott
7.5.1 Abbott Company Summary
7.5.2 Abbott Business Overview
7.5.3 Abbott Hospital-Acquired Infection Control Major Product Offerings
7.5.4 Abbott Hospital-Acquired Infection Control Revenue in Global Market (2018-2023)
7.5.5 Abbott Key News & Latest Developments
7.6 BD
7.6.1 BD Company Summary
7.6.2 BD Business Overview
7.6.3 BD Hospital-Acquired Infection Control Major Product Offerings
7.6.4 BD Hospital-Acquired Infection Control Revenue in Global Market (2018-2023)
7.6.5 BD Key News & Latest Developments
7.7 Cepheid
7.7.1 Cepheid Company Summary
7.7.2 Cepheid Business Overview
7.7.3 Cepheid Hospital-Acquired Infection Control Major Product Offerings
7.7.4 Cepheid Hospital-Acquired Infection Control Revenue in Global Market (2018-2023)
7.7.5 Cepheid Key News & Latest Developments
7.8 Getinge Group
7.8.1 Getinge Group Company Summary
7.8.2 Getinge Group Business Overview
7.8.3 Getinge Group Hospital-Acquired Infection Control Major Product Offerings
7.8.4 Getinge Group Hospital-Acquired Infection Control Revenue in Global Market (2018-2023)
7.8.5 Getinge Group Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Hospital-Acquired Infection Control Market Opportunities & Trends in Global Market
Table 2. Hospital-Acquired Infection Control Market Drivers in Global Market
Table 3. Hospital-Acquired Infection Control Market Restraints in Global Market
Table 4. Key Players of Hospital-Acquired Infection Control in Global Market
Table 5. Top Hospital-Acquired Infection Control Players in Global Market, Ranking by Revenue (2022)
Table 6. Global Hospital-Acquired Infection Control Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global Hospital-Acquired Infection Control Revenue Share by Companies, 2018-2023
Table 8. Global Companies Hospital-Acquired Infection Control Product Type
Table 9. List of Global Tier 1 Hospital-Acquired Infection Control Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Hospital-Acquired Infection Control Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Hospital-Acquired Infection Control Revenue, (US$, Mn), 2022 & 2030
Table 12. By Type - Hospital-Acquired Infection Control Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - Hospital-Acquired Infection Control Revenue in Global (US$, Mn), 2024-2030
Table 14. By Application ? Global Hospital-Acquired Infection Control Revenue, (US$, Mn), 2022 & 2030
Table 15. By Application - Hospital-Acquired Infection Control Revenue in Global (US$, Mn), 2018-2023
Table 16. By Application - Hospital-Acquired Infection Control Revenue in Global (US$, Mn), 2024-2030
Table 17. By Region ? Global Hospital-Acquired Infection Control Revenue, (US$, Mn), 2022 & 2030
Table 18. By Region - Global Hospital-Acquired Infection Control Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global Hospital-Acquired Infection Control Revenue (US$, Mn), 2024-2030
Table 20. By Country - North America Hospital-Acquired Infection Control Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America Hospital-Acquired Infection Control Revenue, (US$, Mn), 2024-2030
Table 22. By Country - Europe Hospital-Acquired Infection Control Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe Hospital-Acquired Infection Control Revenue, (US$, Mn), 2024-2030
Table 24. By Region - Asia Hospital-Acquired Infection Control Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia Hospital-Acquired Infection Control Revenue, (US$, Mn), 2024-2030
Table 26. By Country - South America Hospital-Acquired Infection Control Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America Hospital-Acquired Infection Control Revenue, (US$, Mn), 2024-2030
Table 28. By Country - Middle East & Africa Hospital-Acquired Infection Control Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa Hospital-Acquired Infection Control Revenue, (US$, Mn), 2024-2030
Table 30. GSK Company Summary
Table 31. GSK Hospital-Acquired Infection Control Product Offerings
Table 32. GSK Hospital-Acquired Infection Control Revenue (US$, Mn) & (2018-2023)
Table 33. GSK Key News & Latest Developments
Table 34. Merck Company Summary
Table 35. Merck Hospital-Acquired Infection Control Product Offerings
Table 36. Merck Hospital-Acquired Infection Control Revenue (US$, Mn) & (2018-2023)
Table 37. Merck Key News & Latest Developments
Table 38. Pfizer Company Summary
Table 39. Pfizer Hospital-Acquired Infection Control Product Offerings
Table 40. Pfizer Hospital-Acquired Infection Control Revenue (US$, Mn) & (2018-2023)
Table 41. Pfizer Key News & Latest Developments
Table 42. 3M Company Summary
Table 43. 3M Hospital-Acquired Infection Control Product Offerings
Table 44. 3M Hospital-Acquired Infection Control Revenue (US$, Mn) & (2018-2023)
Table 45. 3M Key News & Latest Developments
Table 46. Abbott Company Summary
Table 47. Abbott Hospital-Acquired Infection Control Product Offerings
Table 48. Abbott Hospital-Acquired Infection Control Revenue (US$, Mn) & (2018-2023)
Table 49. Abbott Key News & Latest Developments
Table 50. BD Company Summary
Table 51. BD Hospital-Acquired Infection Control Product Offerings
Table 52. BD Hospital-Acquired Infection Control Revenue (US$, Mn) & (2018-2023)
Table 53. BD Key News & Latest Developments
Table 54. Cepheid Company Summary
Table 55. Cepheid Hospital-Acquired Infection Control Product Offerings
Table 56. Cepheid Hospital-Acquired Infection Control Revenue (US$, Mn) & (2018-2023)
Table 57. Cepheid Key News & Latest Developments
Table 58. Getinge Group Company Summary
Table 59. Getinge Group Hospital-Acquired Infection Control Product Offerings
Table 60. Getinge Group Hospital-Acquired Infection Control Revenue (US$, Mn) & (2018-2023)
Table 61. Getinge Group Key News & Latest Developments
List of Figures
Figure 1. Hospital-Acquired Infection Control Segment by Type in 2022
Figure 2. Hospital-Acquired Infection Control Segment by Application in 2022
Figure 3. Global Hospital-Acquired Infection Control Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Hospital-Acquired Infection Control Market Size: 2022 VS 2030 (US$, Mn)
Figure 6. Global Hospital-Acquired Infection Control Revenue, 2018-2030 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Hospital-Acquired Infection Control Revenue in 2022
Figure 8. By Type - Global Hospital-Acquired Infection Control Revenue Market Share, 2018-2030
Figure 9. By Application - Global Hospital-Acquired Infection Control Revenue Market Share, 2018-2030
Figure 10. By Type - Global Hospital-Acquired Infection Control Revenue, (US$, Mn), 2022 & 2030
Figure 11. By Type - Global Hospital-Acquired Infection Control Revenue Market Share, 2018-2030
Figure 12. By Application - Global Hospital-Acquired Infection Control Revenue, (US$, Mn), 2022 & 2030
Figure 13. By Application - Global Hospital-Acquired Infection Control Revenue Market Share, 2018-2030
Figure 14. By Region - Global Hospital-Acquired Infection Control Revenue Market Share, 2018-2030
Figure 15. By Country - North America Hospital-Acquired Infection Control Revenue Market Share, 2018-2030
Figure 16. US Hospital-Acquired Infection Control Revenue, (US$, Mn), 2018-2030
Figure 17. Canada Hospital-Acquired Infection Control Revenue, (US$, Mn), 2018-2030
Figure 18. Mexico Hospital-Acquired Infection Control Revenue, (US$, Mn), 2018-2030
Figure 19. By Country - Europe Hospital-Acquired Infection Control Revenue Market Share, 2018-2030
Figure 20. Germany Hospital-Acquired Infection Control Revenue, (US$, Mn), 2018-2030
Figure 21. France Hospital-Acquired Infection Control Revenue, (US$, Mn), 2018-2030
Figure 22. U.K. Hospital-Acquired Infection Control Revenue, (US$, Mn), 2018-2030
Figure 23. Italy Hospital-Acquired Infection Control Revenue, (US$, Mn), 2018-2030
Figure 24. Russia Hospital-Acquired Infection Control Revenue, (US$, Mn), 2018-2030
Figure 25. Nordic Countries Hospital-Acquired Infection Control Revenue, (US$, Mn), 2018-2030
Figure 26. Benelux Hospital-Acquired Infection Control Revenue, (US$, Mn), 2018-2030
Figure 27. By Region - Asia Hospital-Acquired Infection Control Revenue Market Share, 2018-2030
Figure 28. China Hospital-Acquired Infection Control Revenue, (US$, Mn), 2018-2030
Figure 29. Japan Hospital-Acquired Infection Control Revenue, (US$, Mn), 2018-2030
Figure 30. South Korea Hospital-Acquired Infection Control Revenue, (US$, Mn), 2018-2030
Figure 31. Southeast Asia Hospital-Acquired Infection Control Revenue, (US$, Mn), 2018-2030
Figure 32. India Hospital-Acquired Infection Control Revenue, (US$, Mn), 2018-2030
Figure 33. By Country - South America Hospital-Acquired Infection Control Revenue Market Share, 2018-2030
Figure 34. Brazil Hospital-Acquired Infection Control Revenue, (US$, Mn), 2018-2030
Figure 35. Argentina Hospital-Acquired Infection Control Revenue, (US$, Mn), 2018-2030
Figure 36. By Country - Middle East & Africa Hospital-Acquired Infection Control Revenue Market Share, 2018-2030
Figure 37. Turkey Hospital-Acquired Infection Control Revenue, (US$, Mn), 2018-2030
Figure 38. Israel Hospital-Acquired Infection Control Revenue, (US$, Mn), 2018-2030
Figure 39. Saudi Arabia Hospital-Acquired Infection Control Revenue, (US$, Mn), 2018-2030
Figure 40. UAE Hospital-Acquired Infection Control Revenue, (US$, Mn), 2018-2030
Figure 41. GSK Hospital-Acquired Infection Control Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. Merck Hospital-Acquired Infection Control Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 43. Pfizer Hospital-Acquired Infection Control Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 44. 3M Hospital-Acquired Infection Control Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 45. Abbott Hospital-Acquired Infection Control Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 46. BD Hospital-Acquired Infection Control Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 47. Cepheid Hospital-Acquired Infection Control Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 48. Getinge Group Hospital-Acquired Infection Control Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
